1,3-ditolylguanidine has been researched along with bd 1063 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bowen, WD; de Costa, BR; Dominguez, C; Gu, ZQ; He, XS; Linders, JT; Williams, W | 1 |
| Abate, C; Berardi, F; Cassano, G; Ferorelli, S; Gasparre, G; Niso, M; Perrone, R | 1 |
2 other study(ies) available for 1,3-ditolylguanidine and bd 1063
| Article | Year |
|---|---|
Synthesis and evaluation of conformationally restricted N-[2-(3,4-dichlorophenyl)ethyl]-N-methyl-2-(1-pyrrolidinyl)ethylamines at sigma receptors. 2. Piperazines, bicyclic amines, bridged bicyclic amines, and miscellaneous compounds.
Topics: Animals; Brain; Ethylamines; Guinea Pigs; Receptors, sigma; Structure-Activity Relationship | 1993 |
Investigation of σ receptors agonist/antagonist activity through N-(6-methoxytetralin-1-yl)- and N-(6-methoxynaphthalen-1-yl)alkyl derivatives of polymethylpiperidines.
Topics: Calcium; Cell Line, Tumor; Cell Proliferation; Female; Humans; Methylation; Naphthalenes; Piperidines; Receptors, sigma; Tetrahydronaphthalenes | 2013 |